Business Context and Reporting Period
This Form 8-K filing by Amrize Ltd (NYSE: AMRZ) covers events occurring on February 11, 2026. The company, incorporated in Switzerland, reported changes to its Board of Directors and Audit Committee composition.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Board Departure: Theresa Drew stepped down from the Board of Directors. The resignation is not related to any disagreement regarding the Company's operations, policies, or practices.
- Audit Committee Appointments: Robert S. Rivkin was appointed Chair of the Audit Committee, having served as a member since June 2025.
- New Committee Member: Holli Ladhani was appointed to the Audit Committee as a qualified "audit committee financial expert" and was determined to satisfy NYSE financial literacy requirements.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document is limited to the announcement of personnel changes.
Investor Verification Checklist
- Verify the effective date of Theresa Drew's departure and any potential impact on board quorum or committee composition.
- Confirm Robert S. Rivkin's tenure history and qualifications as the new Audit Committee Chair.
- Review Holli Ladhani's background to validate her status as an "audit committee financial expert."
- Check for any subsequent filings regarding the appointment of a replacement director for the vacancy left by Ms. Drew.